JUVENILE POLYMYOSITIS
Clinical trials for JUVENILE POLYMYOSITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE POLYMYOSITIS trials appear
Sign up with your email to follow new studies for JUVENILE POLYMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy aims to reset immune system in devastating muscle diseases
Disease control Recruiting nowThis study is testing a one-time cell therapy called CABA-201 for adults and children with rare autoimmune diseases that cause severe muscle weakness and inflammation. The goal is to see if this treatment can safely reduce disease activity and improve muscle strength, potentially…
Matched conditions: JUVENILE POLYMYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists hunt for environmental causes of crippling muscle disease
Knowledge-focused Recruiting nowThis study aims to understand if certain environmental factors, like infections, chemicals, or stressful events, might trigger a rare autoimmune disease that weakens muscles and can affect the lungs. Researchers will compare the past exposures of 580 people—including those with t…
Matched conditions: JUVENILE POLYMYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC